Back
Neurogene Stock Predictions
Sponsored
NGNE
Sponsored
Multimillionaire Trader Reveals His #1 Gold Pick
Click here to learn more about this game-changing opportunity.
Sell
50
NGNE
Neurogene
Last Price:
49.12
Seasonality Move:
28.65%
7 Day Trial
ALL ACCESS PASS
$
7
Urgent: The Biggest Gold Bull Market in History Is Here
Click here for urgent details - don't miss out.Neurogene Stock Forecast
- Over the next 52 weeks, Neurogene has on average historically risen by 47.1% based on the past 10 years of stock performance.
- Neurogene has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
-
Is Neurogene Stock Undervalued?
The current Neurogene [NGNE] share price is $49.43. The Score for NGNE is 50, which is 0% below its historic median score of 50, and infers higher risk than normal. - NGNE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Neurogene Stock Go Up Next Year?
- Over the next 52 weeks, Neurogene has on average historically risen by 47.1% based on the past 10 years of stock performance.
Neurogene Stock Rating
Sell
50
Neurogene (NGNE)
is a Sell
Is Neurogene overpriced?
- Neurogene has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
Neurogene Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurogene.com
52-Week Data
52-Week High:
53.00
52-Week Low:
12.49
Prediction Charts
Market Cap:
642.27M
Price in USD:
49.43
Volume:
170.98K
Beta:
-1.27
Technical Analysis
SMA50:
39.14
SMA100:
38.49
SMA200:
36.07
52-Wk Change:
215.24%
Stock Predictions
-
Is Neurogene stock public?
Yes, Neurogene is a publicly traded company. -
What is the Neurogene stock quote today?
The Neurogene stock price is 49.43 USD today. -
How to buy Neurogene stock online?
You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Sep-24 | 40.10 | 40.83 | 42.29 | 39.41 |
Sep-25 | 41.02 | 41.93 | 44.75 | 40.75 |
Sep-26 | 42.40 | 39.42 | 43.78 | 38.56 |
Sep-27 | 39.87 | 40.33 | 41.45 | 39.86 |
Sep-30 | 40.23 | 41.96 | 43.05 | 39.25 |
Oct-1 | 41.68 | 39.94 | 41.68 | 38.35 |
Oct-2 | 39.48 | 41.75 | 42.00 | 38.14 |
Oct-3 | 41.55 | 44.68 | 44.68 | 41.40 |
Oct-4 | 44.89 | 48.59 | 51.30 | 44.37 |
Oct-7 | 48.40 | 47.60 | 48.92 | 46.32 |
Oct-8 | 47.60 | 50.34 | 50.59 | 47.53 |
Oct-9 | 50.32 | 49.55 | 51.42 | 48.41 |
Oct-10 | 48.73 | 48.15 | 50.29 | 47.87 |
Oct-11 | 48.15 | 49.43 | 50.13 | 47.81 |
Neurogene Earnings
Neurogene Earnings Report: Per Share Neurogene Earnings Q1 Q2 Q3 and Q4 last year and next year.
Neurogene Forecast Revenue Growth
Neurogene Stock Analysis: Historical quarterly revenues per share for Neurogene and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.
* Neurogene stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.